Font Size: a A A

Research On Debt Risk Control Of Zhejiang Hisun Pharmaceutical

Posted on:2020-02-13Degree:MasterType:Thesis
Country:ChinaCandidate:X YangFull Text:PDF
GTID:2439330602960553Subject:Business administration
Abstract/Summary:PDF Full Text Request
At present,the pharmaceutical industry is facing many difficulties.The market environment and national policies are deeply affecting the development of China's pharmaceutical industry.Many pharmaceutical enterprises have gradually exposed such problems as insufficient solvency,inefficient use of debt funds and lack of effective control over debt funds.According to the data,Zhejiang Hisun Pharmaceutical has been losing money for five consecutive years,and the debt scale has exceeded 10 billion over the years.If we do not take timely measures to control it,it will inevitably lead to the situation of risk out of control.Therefore,it is particularly important to strengthen the control of corporate debt risk.This thesis chooses Zhejiang Hisun Pharmaceutical as the research object,adopts comparative analysis method and case analysis method,and combines the theory of debt risk control to analyze the debt risk control of Zhejiang Hisun Pharmaceutical.Firstly,this thesis clarifies the relevant research background,research status of theoretical achievements at home and abroad,research ideas and research methods;secondly,combining the theory of debt risk control with the financial data of Zhejiang Hisun Pharmaceutical,it makes a detailed analysis of the recent operation situation,debt scale,debt structure,debt Solvency Index of Zhejiang Hisun Pharmaceutical;secondly,it carries on the debt scale,debt structure and debt repayment index.Comparing the industry data of debt ability,it points out that the debt scale of Zhejiang Hisun Pharmaceutical is too large,the ratio of assets to liabilities is too high,and the debt-paying ability is declining.Finally,it gives the corresponding suggestions and measures.The suggestions on strengthening debt risk control of Zhejiang Hisun Pharmaceutical mainly include the following points:strictly controlling.debt scale and reducing unnecessary capital expenditure;rationally allocating debt structure to reduce debt risk;establishing an index system for debt risk analysis,establishing and improving an efficient debt risk early warning system;establishing a defense mechanism to transfer corporate debt risk;and realizing diversified financing.Capital;Strengthen the construction of financial personnel in enterprises.
Keywords/Search Tags:risk management, solvency, debt risk control
PDF Full Text Request
Related items